Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Fujirebio Inc.
DescriptionELISA that detects soluble mesothelin-related peptides (SMRP) in the blood
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDaignose epithelioid or biphasic mesothelioma; Diagnose mesothelioma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today